Brought to you by 
Pharmacia licenses Nastech's apomorphine; returns rights
17 Apr 2003
Executive Summary
Pharmacia licensed exclusive worldwide rights to develop and market Nastech Pharmaceutical's (nasal drug delivery) apomorphine product to treat erectile dysfunction and female sexual dysfunction.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Terminated
Deal Type
-
Alliance
- Includes Contract
- Includes Equity
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Pharmacia licenses Nastech's apomorphine; returns rights
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice